+0.090 (+5.96%)
Range 1.470 - 1.600   (8.84%)
Open 1.540
Previous Close 1.510
Buy Price 2.160
Buy Volume -
Sell Price 2.170
Sell Volume -
Volume 994,642
Value -
Measurement Type Value
EPS (USD) -0.258
Trailing EPS (USD) -0.19
NAV (USD) 0.487
Cash In Hand (USD) 0.015
Dividend -
Dividend Yield (%) -
PE -
Trailing PE -
Price / NAV 3.286
Price / Cash In Hand 106.667
Issued & Paid-up Shares 138,859,000
Treasury Shares -
Market Cap (M) 164.416
Par Value (USD) n.a.
Beta - 75 Days -
R-Squared - 75 Days(%) -
Beta - 500 Days -
R-Squared - 500 Days(%) -
Under CPF Investment Scheme (CPFIS) No
Index Components
Delayed prices. Updated at 28 Nov 2020 02:00.
Data powered by

Upcoming Events

* Stock event date based on US timezone.


Release Date 10 Mar 2021
View All Events


22nd Century Group, Inc. (22nd Century Group) through its subsidiary, 22nd Century Limited, LLC (22nd Century Ltd), which is a plant biotechnology company. The Company focuses on tobacco harm reduction and smoking cessation products produced from modifying the nicotine content in tobacco plants through genetic engineering and plant breeding. Goodrich Tobacco Company, LLC (Goodrich Tobacco) and Hercules Pharmaceuticals, LLC (Hercules Pharmaceuticals) are subsidiaries of 22nd Century Ltd. Goodrich Tobacco is focused on commercial tobacco products and potentially reduced-risk or modified risk tobacco products. Hercules Pharmaceuticals is focused on X-22, a prescription smoking cessation aid in development. In September 2014, the Company acquired NASCO Products, LLC.

Loading Chart...